GPX4 and neoplasm: Recent studies in BLCA have highlighted the therapeutic potential of ferroptosis induction, showing that ferroptosis‐related genes (e.g., SLC7A11, GPX4) are closely associated with tumor progression and immune infiltration (Hu et al. 2023; Liu, Luo, et al. 2024).